Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.90 USD
Change Today +0.24 / 2.25%
Volume 2.5M
KERX On Other Exchanges
Symbol
Exchange
KERX is not on other exchanges.
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ron Bentsur

Chief Executive Officer, Director and Member of Research & Development Committee, Keryx Biopharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 3 different industries.

See Board Relationships
48$9,161,377
As of Fiscal Year 2014

Background*

Mr. Ron Bentsur has been the Chief Executive Officer of Keryx Biopharmaceuticals Inc. since May 20, 2009. Mr. Bentsur served as the Co-Chief Executive Officer of XTL Biopharmaceuticals Ltd. from February 2009 to May 2009. He served as the Chief Executive Officer of XTL Biopharmaceuticals Ltd. from January 2006 to February 2009. He served as the Chief Executive Officer of XTL Biopharmaceuticals, Inc. ("XTL") from January 2006 to April 2009. Prior to his tenure at XTL, ...

Read Full Background

Corporate Headquarters*

750 Lexington Avenue
New York, New York 10022

United States

Phone: 212-531-5965
Fax: 212-531-5961

Board Members Memberships*

2009-Present
Chief Executive Officer, Director and Member of Research & Development Committee
2009-Present
Independent Director, Member of Audit Committee and Member of Compensation Committee

Education*

MBA
New York University - Leonard N. Stern School of Business
BA
Hebrew University of Jerusalem

Other Affiliations*

Annual Compensation*

Salary$491,667
Total Annual Compensation$491,667

Stock Options*

Restricted Stock Awards$7,686,097
Exercisable Options904,007
Exercisable Options Value$11,651,589
Unexercisable Options98,925
Unexercisable Options Value$514,567
Total Value of Options$12,166,155
Total Number of Options1,002,932

Total Compensation*

Total Annual Cash Compensation$836,167
Total Short Term Compensation$491,667
Other Long Term Compensation$7,686,097
Total Calculated Compensation$9,161,377
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KERX:US $10.90 USD +0.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KERYX BIOPHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.